10X Genomics

Forecast & Rating18 analysts currently cover 10X Genomics, with about 33.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $77.50, about 6.2% upside from the current price of $72.96. Price targets range from $50.00 to $110.00 — a wide spread, showing clear disagreement over just how much 10X Genomics can rise. Historically, about 50.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on 10X Genomics's outlook. Data as of Oct 26, 2026; for reference only and not investment advice.